Search results
Results from the WOW.Com Content Network
Elmar-M 24 mm f /3.8 ASPH. Summaron-M 28mm f /5.6. Summilux-M 28 mm f /1.4 ASPH. ... Elmarit-S 1:2.8/45 mm ASPH. Elmarit-S 1:2.8/45 mm ASPH. CS; Summarit-S 1:2.5/70 ...
Elmarit-S 1:2.8/30 mm ASPH. CS; Elmarit-S 1:2.8/45 mm ASPH. Elmarit-S 1:2.8/45 mm ASPH. CS; For the Leica L Mount. Elmarit-TL 18 mm f/2.8 ASPH. APO-Macro-Elmarit-TL 60 f/2.8 ASPH. Vario-Elmarit-SL 24-70 f/2.8 ASPH. Vario-Elmarit-SL 1:2.8–4 / 24–90 ASPH. APO-Vario-Elmarit-SL 1:2.8–4 / 90–280; For the Four Thirds mount [a 1] D Vario ...
Current Elmar lenses have a maximum aperture of f/3.8 or f/4, as in the Elmar-M 24 mm f/3.8 and Tri-Elmar-M 16-18-21 mm f/4. [1] The term Elmar is sometimes combined with: Super, Tele, APO, Macro or Vario. Leica also uses the name Elmarit for some lenses.
There are some variations in lens markings, depending on which camera it was bundled with initially; engraved on the ring around the front element for the version bundled with the Panasonic DMC-L1, the brand ("LEICA") is by itself on one side, opposite the lens name and data ("D VARIO-ELMARIT 1:2.8–3.5/14-50 ASPH.
The Leica Vario-Elmarit-SL 24-90mm F2.8-4 ASPH is an interchangeable standard zoom lens for Leica L mount, announced by Leica on October 20, 2015. [1]A review in PCMag UK praised the lens for its sharpness, low distortion and weatherproof, optically stabilised design, while also drawing attention to its vignetting of up to 5.5 stops at 24mm.
An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain). Equianalgesic charts are used for calculation of an equivalent dose (a dose which would offer an equal amount of analgesia) between different analgesics. [1]
[14] [15] [16] The most common side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation. [14] [17] [18] [19] [29] It was approved for medical use in the US in 2017. [14] [30] In 2022, it was the 48th most commonly prescribed medication in the United States, with more than 13 million prescriptions. [31] [32]
Agomelatine acts as a highly potent and selective melatonin MT 1 and MT 2 receptor agonist (K i = 0.1 nM and 0.12 nM, respectively) and also as a relatively weak serotonin 5-HT 2B and 5-HT 2C receptor antagonist (K i = 660 nM and 631 nM, respectively; ~6,000-fold lower than for the melatonin receptors).